These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

605 related items for PubMed ID: 9694527

  • 21. Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders.
    Stemmelin J, Cohen C, Terranova JP, Lopez-Grancha M, Pichat P, Bergis O, Decobert M, Santucci V, Françon D, Alonso R, Stahl SM, Keane P, Avenet P, Scatton B, le Fur G, Griebel G.
    Neuropsychopharmacology; 2008 Feb; 33(3):574-87. PubMed ID: 17460614
    [Abstract] [Full Text] [Related]

  • 22. Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.
    Griebel G, Simiand J, Serradeil-Le Gal C, Wagnon J, Pascal M, Scatton B, Maffrand JP, Soubrie P.
    Proc Natl Acad Sci U S A; 2002 Apr 30; 99(9):6370-5. PubMed ID: 11959912
    [Abstract] [Full Text] [Related]

  • 23. [Behavioral pharmacological and electroencephalographic effects of the 5-HT1A partial agonist ipsapirone].
    Yamamoto T, Shibata S, Teshima K, Inoue Y, Ushio M, Tominaga K, Ohno M, Watanabe S, Ueki S.
    Nihon Yakurigaku Zasshi; 1991 Jul 30; 98(1):41-52. PubMed ID: 1679740
    [Abstract] [Full Text] [Related]

  • 24. Tolerance in the anxiolytic profile following repeated administration of diazepam but not buspirone is associated with a decrease in the responsiveness of postsynaptic 5-HT-1A receptors.
    Khan A, Haleem DJ.
    Acta Biol Hung; 2007 Dec 30; 58(4):345-57. PubMed ID: 18277461
    [Abstract] [Full Text] [Related]

  • 25. Anxiolytic-like effects of the new arylpiperazine derivatives containing isonicotinic and picolinic nuclei: behavioral and biochemical studies.
    Kędzierska E, Fiorino F, Gibuła E, Corvino A, Giordano F, Herbet M, Dudka J, Poleszak E, Wlaź P, Kotlińska JH.
    Fundam Clin Pharmacol; 2019 Jun 30; 33(3):254-266. PubMed ID: 30506804
    [Abstract] [Full Text] [Related]

  • 26. Anxiolytic activity of SC-48274 compared with those of buspirone and diazepam in experimental anxiety models.
    Ogawa N, Hara C, Takaki S.
    Jpn J Pharmacol; 1993 Feb 30; 61(2):115-21. PubMed ID: 8096257
    [Abstract] [Full Text] [Related]

  • 27. Profile of action of a novel 5-hydroxytryptamine1A receptor ligand E-4424 to inhibit aversive behavior in the mouse, rat and marmoset.
    Costall B, Domeney AM, Farre AJ, Kelly ME, Martinez L, Naylor RJ.
    J Pharmacol Exp Ther; 1992 Jul 30; 262(1):90-8. PubMed ID: 1352556
    [Abstract] [Full Text] [Related]

  • 28. The benzodiazepine diazepam demonstrates the usefulness of Syrian hamsters as a model for anxiety testing: evaluation of other classes of anxiolytics in comparison to diazepam.
    Gannon RL, Lungwitz E, Batista N, Hester I, Huntley C, Peacock A, Delagrange P, Millan MJ.
    Behav Brain Res; 2011 Mar 17; 218(1):8-14. PubMed ID: 21094664
    [Abstract] [Full Text] [Related]

  • 29. Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat.
    Zorrilla EP, Valdez GR, Nozulak J, Koob GF, Markou A.
    Brain Res; 2002 Oct 18; 952(2):188-99. PubMed ID: 12376179
    [Abstract] [Full Text] [Related]

  • 30. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress.
    Yamaguchi T, Tsujimatsu A, Kumamoto H, Izumi T, Ohmura Y, Yoshida T, Yoshioka M.
    J Ethnopharmacol; 2012 Sep 28; 143(2):533-9. PubMed ID: 22819689
    [Abstract] [Full Text] [Related]

  • 31. Study of the modulatory activity of BZ (omega) receptor ligands on defensive behaviors in mice: evaluation of the importance of intrinsic efficacy and receptor subtype selectivity.
    Griebel G, Perrault G, Sanger DJ.
    Prog Neuropsychopharmacol Biol Psychiatry; 1999 Jan 28; 23(1):81-98. PubMed ID: 10368858
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
    Harada K, Aota M, Inoue T, Matsuda R, Mihara T, Yamaji T, Ishibashi K, Matsuoka N.
    Eur J Pharmacol; 2006 Dec 28; 553(1-3):171-84. PubMed ID: 17074317
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. An evaluation of the elevated plus-maze test using the novel anxiolytic buspirone.
    Moser PC.
    Psychopharmacology (Berl); 1989 Dec 28; 99(1):48-53. PubMed ID: 2528779
    [Abstract] [Full Text] [Related]

  • 38. Anxiolytic-like effects of the corticotropin-releasing factor1 (CRF1) antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] administered acutely or chronically at doses occupying central CRF1 receptors in rats.
    Lelas S, Wong H, Li YW, Heman KL, Ward KA, Zeller KL, Sieracki KK, Polino JL, Godonis HE, Ren SX, Yan XX, Arneric SP, Robertson DW, Hartig PR, Grossman S, Trainor GL, Taub RA, Zaczek R, Gilligan PJ, McElroy JF.
    J Pharmacol Exp Ther; 2004 Apr 28; 309(1):293-302. PubMed ID: 14742750
    [Abstract] [Full Text] [Related]

  • 39. Diazepam, but not buspirone, induces similar anxiolytic-like actions in lactating and ovariectomized Wistar rats.
    Fernández-Guasti A, Ferreira A, Picazo O.
    Pharmacol Biochem Behav; 2001 Sep 28; 70(1):85-93. PubMed ID: 11566145
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.